BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/10/2023 8:15:35 AM | Browse: 163 | Download: 396
 |
Received |
|
2023-05-31 17:06 |
|
Peer-Review Started |
|
2023-05-31 17:08 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-06-26 21:27 |
|
Revised |
|
2023-07-07 20:50 |
|
Second Decision |
|
2023-09-01 02:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-09-01 09:37 |
|
Articles in Press |
|
2023-09-01 09:37 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-09-27 10:49 |
|
Publish the Manuscript Online |
|
2023-10-10 08:15 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Real-world clinical effectiveness of sorafenib among patients with unresectable hepatocellular carcinoma at two centers in the United States
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Daneng Li, Stephen B Gruber, Shrividya Iyer, Sanjay Gupta and Mohamedtaki Tejani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Daneng Li, MD, Associate Professor, Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, No. 1500 E. Duarte Road, Duarte, CA 91010, United States. danli@coh.org |
| Key Words |
Retrospective observational study; Sorafenib; Hepatocellular carcinoma; Clinical effectiveness |
| Core Tip |
As treatment options evolve for hepatocellular carcinoma (HCC) it is important to assess and understand the clinical outcomes with older treatment options in diverse real-world clinical practice settings to inform clinical decision making and identify the right patient for the right drug. The current study aimed to assess the patient characteristics and clinical effectiveness of sorafenib as first-line therapy in unresectable HCC patients treated in both academic and community practice settings in the United States. |
| Publish Date |
2023-10-10 08:15 |
| Citation |
Li D, Gruber S, Iyer S, Gupta S, Tejani M. Real-world clinical effectiveness of sorafenib among patients with unresectable hepatocellular carcinoma at two centers in the United States. World J Gastrointest Oncol 2023; 15(10): 1796-1806 |
| URL |
https://www.wjgnet.com/1948-5204/full/v15/i10/1796.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v15.i10.1796 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
